Pathogenetic therapy of systemic scleroderma | Zendy

И. Г. Салихов | Zendy; R. A. Bodrova | Zendy; Л. Е. Зиганшина | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pathogenetic therapy of systemic scleroderma

Author(s) -

И. Г. Салихов,

R. A. Bodrova,

Л. Е. Зиганшина

Publication year - 2001

Publication title -

kazan medical journal

Language(s) - English

Resource type - Journals

eISSN - 2587-9359

pISSN - 0368-4814

DOI - 10.17816/kazmj84126

Subject(s) - scleroderma (fungus) , medicine , systemic scleroderma , connective tissue , connective tissue disease , fibrosis , systemic disease , pathology , dermatology , progressive systemic sclerosis , connective tissue disorder , systemic therapy , disease , autoimmune disease , cancer , breast cancer , inoculation

Systemic scleroderma (SSD) is a progressive polysyndromic disease with characteristic changes in the skin, musculoskeletal system, internal organs and widespread vasospastic disorders based on connective tissue lesions with predominant vascular fibrosis of the type of obliterating endarteriolitis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research